Jessica Gibson

Jessica Gibson is CEO and co-founder of Ariel Precision Medicine. She has led the development, clinical validation and commercial launch of Ariel’s first product, PancreasDx®, and a cloud-based digital health platform designed to simplify the management of complex patients with Ariel’s proprietary expert system. Before entering industry, she worked in emergency care and in academia at the University of Pittsburgh.